Angelika Amon

Angelika Amon
Angelika Amon
	Angelika Amon in October 2017.
Born	January 10, 1967; Vienna, Austria
Died	October 29, 2020 (aged 53); Cambridge, Massachusetts, U.S.
Nationality	Austrian
Citizenship	Austria & United States
Alma mater	University of Vienna (B.S.); University of Vienna (PhD, 1993);
Known for	Chromosome duplication and cell division
Awards	1998 Presidential Early Career Award for Scientists and Engineers; 2003 Alan T. Waterman Award; 2003 Eli Lilly and Company-Elanco Research Award; 2007 Paul Marks Prize for Cancer Research (shared with Todd R. Golub and Gregory J. Hannon); 2008 NAS Award in Molecular Biology; 2013 Ernst Jung Prize; 2018 Vanderbilt Prize in Biomedical Science; 2019 Breakthrough Prize in Life Sciences; 2019 Vilcek Prize;
	Scientific career
Institutions	Whitehead Institute (1994–1999); Massachusetts Institute of Technology (1999–2020); Research Institute of Molecular Pathology;
Doctoral advisor	Kim Nasmyth

Angelika Amon, PhD (January 10, 1967 – October 29, 2020) was an Austrian-American molecular and cell biologist. She was the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States.

Amon's research focused on how chromosomes are regulated and repeated in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.

Amon died of ovarian cancer on October 29, 2020 in Cambridge at the age of 53.[1]

References

Schroeder, Bendta (October 30, 2020). "Angelika Amon, cell biologist who pioneered research on chromosome imbalance, dies at 53". MIT News. Massachusetts Institute of Technology. Retrieved October 31, 2020.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.